These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36924095)

  • 1. Current Perspectives on Nanoparticle-based Targeted Drug Delivery Approaches in Breast Cancer Treatment.
    Pandey P; Khan F; Maqsood R; Upadhyay TK
    Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1291-1302. PubMed ID: 36924095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted drug delivery in cervical cancer: Current perspectives.
    Ghosh S; Jayaram P; Kabekkodu SP; Satyamoorthy K
    Eur J Pharmacol; 2022 Feb; 917():174751. PubMed ID: 35021110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers for diagnosis and targeting of breast cancer.
    Sharma A; Jain N; Sareen R
    Biomed Res Int; 2013; 2013():960821. PubMed ID: 23865076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface engineered nanocarriers for the management of breast cancer.
    Nitheesh Y; Pradhan R; Hejmady S; Taliyan R; Singhvi G; Alexander A; Kesharwani P; Dubey SK
    Mater Sci Eng C Mater Biol Appl; 2021 Nov; 130():112441. PubMed ID: 34702526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer.
    Behl A; Chhillar AK
    Recent Pat Anticancer Drug Discov; 2023; 18(3):325-342. PubMed ID: 35702804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Update on Nanocarrier(s) as the Targeted Therapy for Breast Cancer.
    Mukherjee D; Raikwar S
    AAPS PharmSciTech; 2024 Jul; 25(6):153. PubMed ID: 38961013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
    Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
    Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.
    Naz S; Shahzad H; Ali A; Zia M
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):899-916. PubMed ID: 28914553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
    Sultana S; Khan MR; Kumar M; Kumar S; Ali M
    J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-drug delivery system: a promising approach against breast cancer.
    Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
    Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Targeting Nanoparticles for Breast Cancer.
    Alqaraghuli HGJ; Kashanian S; Rafipour R
    Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
    Kumar L; Baldi A; Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.
    Hussain Z; Khan JA; Murtaza S
    Crit Rev Eukaryot Gene Expr; 2018; 28(2):163-175. PubMed ID: 30055543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.
    Choudhury H; Pandey M; Wen LP; Cien LK; Xin H; Yee ANJ; Lee NJ; Gorain B; Amin MCIM; Pichika MR
    Curr Pharm Des; 2020; 26(42):5365-5379. PubMed ID: 32693762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.